Healthcare, Pharma & Life Sciences

PerZeption Wins NEI Phase I SBIR Grant for AMD Vision Test

Boston – September 17, 2026 -- PerZeption Inc. has secured a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute to fund development of a new photostress recovery test for age-related macular degeneration (AMD), a condition affecting an estimated 20 million people in the United States.

NEI Funds Photostress Recovery Test for Earlier AMD Detection

The award backs the project "Efficient Achromatic and Chromatic Photostress Recovery Assessment for Age-related Macular Degeneration," which will be carried out in collaboration with researchers at the Brunson Center for Translational Vision Research at the University of California, Irvine. The work targets how quickly vision recovers after bright-light exposure, a marker of macular health that can reveal functional deficits before they show up on standard acuity tests.

White Memorial Hospitals Generate $1.2B Economic Impact in L.A.

Image
White Memorial Hospitals Generate $1.2B Economic Impact in L.A.

Los Angeles – September 17, 2026 -- Adventist Health White Memorial and Adventist Health White Memorial Montebello generate more than $1.2 billion in annual economic activity and support approximately 5,500 jobs across Los Angeles County, according to a new study.

Study quantifies hospitals' role as economic anchors serving 2.4 million residents

The analysis, conducted by the Los Angeles County Economic Development Corporation (LAEDC), examined the two hospitals' functions as healthcare providers, employers, and community anchors. Combined, they serve more than 2.4 million residents across their primary and secondary service areas.

Armor Health Marks 9/11 Anniversary With Public Safety Pledge

Image
Armor Health Marks 9/11 Anniversary With Public Safety Pledge

Miami – – September 17, 2026 -- Armor Health, a correctional healthcare provider that has served local detention facilities across the United States for more than 22 years, used the 25th anniversary of the September 11 attacks to reaffirm its operational commitment to law enforcement and corrections partners nationwide.

Armor Health ties its correctional healthcare mission to the legacy of first responders

The Miami-based company said its daily work delivering medical and mental health services inside correctional facilities is directly connected to the public safety community honored on the anniversary. Armor Health emphasized its role as a partner to sheriffs, wardens and corrections leaders who oversee incarcerated populations requiring consistent healthcare access.

LifeCare Units Win 2025 SHPBest Awards for Patient Experience

Image
LifeCare Units Win 2025 SHPBest Awards for Patient Experience

Irving, Texas – September 17, 2026 -- Four locations within LifeCare Home Health & Hospice Family have earned 2025 SHPBestTM awards from Strategic Healthcare Programs, ranking among the top tier of providers nationally for patient and caregiver experience.

Eternal Faith Hospice repeats as top 5% national performer

Eternal Faith Hospice in Warner Robins, Georgia, secured the 2025 SHPBestTM Hospice Caregiver Experience Award as a Premier Performer, placing it in the top 5% of SHP's national CAHPS Hospice benchmark. It is the second consecutive year the location has achieved Premier Performer status.

Wichita Falls unit joins top 5% in home health rankings

Beyond Faith Homecare's Wichita Falls, Texas team was named a Premier Performer in the 2025 SHPBestTM Home Health Patient Experience Awards, ranking in the top 5% nationally based on HHCAHPS survey results.

AMP Adds Tema Medicina's ATTIVA Subdermal RF Platform

Image
AMP Adds Tema Medicina's ATTIVA Subdermal RF Platform

Cordova, Tenn. – September 17, 2026 -- Aesthetic Management Partners (AMP) has added ATTIVA®, an intelligent subdermal radiofrequency platform developed by Italy's Tema Medicina S.R.L., to its aesthetic technology portfolio, the company announced.

ATTIVA delivers controlled thermal energy beneath the skin to remodel tissue

The platform uses a fine, insulated cannula to deliver radiofrequency energy into subdermal tissue, producing immediate collagen contraction while supporting progressive collagen and elastin regeneration. It targets the face, neck, jawline, submental area and body, and is designed as a minimally invasive option with limited downtime for most patients.

CordenPharma Invests €80M to Reach 500M Sterile Injectable Units

Image
CordenPharma Invests €80M to Reach 500M Sterile Injectable Units

Basel – September 17, 2026 -- CordenPharma is committing €80 million in multi-year capital expenditure to expand aseptic fill-finish capacity at its FDA- and EMA-approved Caponago site near Milan, targeting total production capacity of up to 500 million sterile injectable units annually.

New 11,000-square-meter facility adds over 50% to site footprint

A key milestone within the total investment was the €13 million acquisition of a new 11,000 m2 commercial building and an adjacent 26,000 m2 plot next to the existing advanced-phase fill-finish area. The expansion, completed September 17, 2026, increases the facility's overall footprint by more than 50%.

AdJane Unveils Nm-nOMV Mucosal Booster for Respiratory Vaccine Franchises

Image
AdJane Unveils Nm-nOMV Mucosal Booster for Respiratory Vaccine Franchises

Delft, Netherlands – September 17, 2026 -- AdJane Biosciences has published a technical white paper detailing a strategy to add a proprietary mucosal-immunity booster to established intramuscular respiratory vaccine franchises, using its clinically validated Nm-nOMV platform derived from Neisseria meningitidis outer membrane vesicles.

The paper, titled 'Boosting mRNA: Mucosal Immunity and a Platform Beyond It,' outlines a heterologous prime-boost regimen: existing intramuscular vaccines would prime systemic immunity, while an intranasal Nm-nOMV dose would generate complementary IgA responses at the respiratory mucosa, the initial entry point for pathogens.

LUX Infusion Acquires Two AICs in New Jersey, New York

Image
LUX Infusion Acquires Two AICs in New Jersey, New York

Plantation, Fla. – September 17, 2026 -- LUX Infusion has acquired two ambulatory infusion centers, South Jersey Pediatric and Adult Infusion Center in Cherry Hill, New Jersey, and Northeast Infusion Therapy in Latham, New York, expanding its clinician-led network into two new states.

LUX Infusion adds two ambulatory infusion centers to its national network

The Plantation, Florida-based company, a portfolio holding of Frazier Healthcare Partners, said the acquisitions extend its footprint of ambulatory infusion centers (AICs) focused on physician-ordered and medically prescribed infusion therapies.

South Jersey center serves both pediatric and adult patients in Cherry Hill

South Jersey Pediatric and Adult Infusion Center delivers physician-ordered infusion services in an outpatient setting serving both pediatric and adult populations, with emphasis on medical supervision and coordination with referring physicians.

Accuray, RaySearch Expand Deal in $8M Adaptive Radiotherapy Push

Image
Accuray, RaySearch Expand Deal in $8M Adaptive Radiotherapy Push

Madison, Wis. – September 17, 2026 -- Accuray Incorporated (NASDAQ: ARAY) and RaySearch Laboratories AB (publ) have signed a definitive agreement expanding their collaboration to accelerate adoption of online adaptive radiation therapy, with Accuray committing to purchase RayStation software licenses valued at $8 million.

Accuray commits $8 million to RaySearch software licenses

Under the deal, Accuray will buy specified RayStation licenses to support commercialization of online adaptive radiation therapy solutions, which both companies will jointly market and support. The agreement also brings RaySearch's RayCare technology into the partnership to simplify connectivity between clinical systems and streamline adaptive workflows.

Pentagon Attack Survivors Return to Burn Center 25 Years Later

Image
Pentagon Attack Survivors Return to Burn Center 25 Years Later

Washington – September 17, 2026 -- Three survivors of the Sept. 11, 2001, Pentagon attack returned to the Burn Center at MedStar Washington Hospital Center 25 years after receiving lifesaving treatment there, marking a milestone for the facility that treated 10 critically injured patients following one of the deadliest terrorist attacks in U.S. history.

Burn Center treated 10 Pentagon patients with severe burns and inhalation injuries in 2001

As the Washington region's only adult Burn Center, the facility mobilized physicians, nurses, therapists and support staff to treat patients requiring multiple reconstructive surgeries, specialized wound care, respiratory support and long-term rehabilitation. President George W. Bush and First Lady Laura Bush visited patients and staff on Sept. 13, 2001, two days after the attack.